Author: Tang, Yueting; Sun, Jiayu; Pan, Huaqin; Yao, Fen; Yuan, Yumeng; Zeng, Mi; Ye, Guangming; Yang, Gui; Zheng, Bokun; Fan, Junli; Pan, Yunbao; Zhao, Ziwu; Guo, Shuang; Liu, Yinjuan; Liao, Fanlu; Duan, Yongwei; Jiao, Xiaoyang; Li, Yirong
Title: Aberrant Cytokine Expression in COVID-19 Patients: Associations between Cytokines and Disease Severity Cord-id: 03ime8qf Document date: 2021_3_31
ID: 03ime8qf
Snippet: Cytokines play pleiotropic, antagonistic, and collaborative in viral disease. The high morbidity and mortality of coronavirus disease 2019 (COVID-19) make it a significant threat to global public health. Elucidating its pathogenesis is essential to finding effective therapy. A retrospective study was conducted on 71 patients hospitalized with COVID-19. Data on cytokines, T lymphocytes, and other clinical and laboratory characteristics were collected from patients with variable disease severity.
Document: Cytokines play pleiotropic, antagonistic, and collaborative in viral disease. The high morbidity and mortality of coronavirus disease 2019 (COVID-19) make it a significant threat to global public health. Elucidating its pathogenesis is essential to finding effective therapy. A retrospective study was conducted on 71 patients hospitalized with COVID-19. Data on cytokines, T lymphocytes, and other clinical and laboratory characteristics were collected from patients with variable disease severity. The effects of cytokines on the overall survival (OS) and event-free survival (EFS) of patients were analyzed. The critically severe and severe patients had higher infection indexes and significant multiple organ function abnormalities than the mild patients (P<0.05). IL-6 and IL-10 were significantly higher in the critically severe patients than in the severe and mild patients (P<0.05). IL-6 and IL-10 were closely associated with white blood cells, neutrophils, T lymphocyte subsets, D-D dimer, blood urea nitrogen, complement C1q, procalcitonin C-reactive protein. Moreover, the IL-6 and IL-10 levels were closely correlated to dyspnea and dizziness (P<0.05). The patients with higher IL-10 levels had shorter OS than the group with lower levels (P<0.05). The older patients with higher levels of single IL-6 or IL-10 tended to have shorter EFS (P<0.05), while the patients who had more elevated IL-6 and IL-10 had shorter OS (P<0.05). The Cox proportional hazard model revealed that IL-6 was the independent factor affecting EFS. IL-6 and IL-10 play crucial roles in COVID-19 prognosis.
Search related documents:
Co phrase search for related documents- absolute count and acute cardiac injury: 1
- absolute count and acute disease phase: 1
- absolute count and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9
- absolute count and low lymphocyte: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- absolute count and low respiratory: 1
- absolute count and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- absolute count and lymphocyte low level: 1
- acid detection kit and lymphocyte count: 1
- acute ards respiratory distress syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute ards respiratory distress syndrome and longitudinal analysis: 1, 2
- acute ards respiratory distress syndrome and low lymphocyte: 1, 2
- acute ards respiratory distress syndrome and low respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
- acute ards respiratory distress syndrome and low respiratory tract: 1, 2
- acute ards respiratory distress syndrome and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acute ards respiratory distress syndrome and lung epithelial cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute ards respiratory distress syndrome and lung immunopathology: 1, 2, 3
- acute ards respiratory distress syndrome and lung production: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute ards respiratory distress syndrome and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
- acute ards respiratory distress syndrome and lymphocyte differentiation: 1
Co phrase search for related documents, hyperlinks ordered by date